Skip to content

Clinical outcomes of AcrySof IQ Vivity intraocular lens in patients with age-related macular degeneration after cataract surgery

Clinical outcomes of AcrySof IQ Vivity intraocular lens in patients with age-related macular degeneration after cataract surgery - VIVITY DMAE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00030673
Enrollment
25
Registered
2023-05-24
Start date
2022-09-06
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eyes operated by cararact surgery

Interventions

Group 1: Patients with AMD who will undergo bilateral conventional cataract surgery by phacoemulsification and intraoperative aberrometry

Sponsors

Promoter's representative of OFTALVIST (Oftalmología Vistahermosa, SL)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing cataract surgery. 2. Early AMD with low or medium risk of progression according to NICE guidelines. 3. Age range of patients between 50 and 80 years.

Exclusion criteria

Exclusion criteria: 1. Intermediate or advanced AMD 2. Other potential ocular alterations 3. Previous ocular surgeries 4. Patients with missing information or missing data will be discarded from the analysis.

Design outcomes

Primary

MeasureTime frame
To evaluate uncorrected monocular distance visual acuity after AcrySof IQ Vivity IOL implantation after cataract surgery in patients with AMD. The study data will be obtained from the clinical history and tests performed on patients treated according to standard clinical practice.

Secondary

MeasureTime frame
- Evaluation of refraction, - Evaluation of the patient's visual acuity at intermediate and near distance (with and without distance correction), - Evaluation of the defocus curve, - Satisfaction evaluation.

Countries

Spain

Contacts

Public ContactMaría Cobo

OFTALVIST

maria.cobo@oftalvist.es+34963513304

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026